Friend or foe: Using systems biology to elucidate interactions between fungi and their hosts

Trends in Microbiology

Volumn 19, Issue 10, 2011, Pages 509-515

  Rizzetto, Lisa ^a   Cavalieri, Duccio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGAL RNA;

ADAPTIVE IMMUNITY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CANDIDIASIS; DENDRITIC CELL; FUNGAL GENE; FUNGAL GENETICS; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE EXPRESSION PROFILING; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MICROBIAL ACTIVITY; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; MOLECULAR INTERACTION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SACCHAROMYCES CEREVISIAE; SYMBIOSIS;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; MYCOSES; SYSTEMS BIOLOGY; VIRULENCE;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; FUNGI; MAMMALIA;

EID: 80053258649     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2011.07.007     Document Type: Review

References (70)

1. Calderone R., et al. Candida albicans: fundamental research on an opportunistic human pathogen. FEMS Yeast Res. 2009, 9:971-972.
2. Netea M.G., et al. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 2008, 6:67-78.
3. Raska M., et al. Candidiasis - do we need to fight or to tolerate the Candida fungus?. Folia Microbiol. (Praha) 2007, 52:297-312.
4. Walker L.A., et al. Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney. Fungal Genet. Biol. 2009, 46:210-219.
5. Liu L., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 2011, 208:1635-1648.
6. Biswas S., et al. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol. Mol. Biol. Rev. 2007, 71:348-376.
7. Kruppa M. Quorum sensing and Candida albicans. Mycoses 2009, 52:1-10.
8. McCormick A., et al. Aspergillus fumigatus: contours of an opportunistic human pathogen. Cell Microbiol. 2010, 12:1535-1543.
9. Round J.L., et al. Coordination of tolerogenic immune responses by the commensal microbiota. J. Autoimmun. 2010, 34:J220-J225.
10. Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes?. Nat. Rev. Immunol. 2010, 10:735-744.
11. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
12. Akira S. TLR signaling. Curr. Top. Microbiol. Immunol. 2006, 311:1-16.
13. Butler G., et al. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 2009, 459:657-662.
14. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007, 449:819-826.
15. Latge J.P. Tasting the fungal cell wall. Cell Microbiol. 2010, 12:863-872.
16. van de Veerdonk F.L., et al. The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 2009, 5:329-340.
17. Romani L. Immunity to fungal infections. Nat. Rev. Immunol. 2011, 11:275-288.
18. Netea M.G., et al. Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin. Microbiol. Infect. 2006, 12:404-409.
19. Goodridge H.S., et al. Beta-glucan recognition by the innate immune system. Immunol. Rev. 2009, 230:38-50.
20. Wheeler R.T., et al. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog. 2008, 4:e1000227.
21. Guerrero A., et al. Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation. Infect. Immun. 2010, 78:1049-1057.
22. Frohner I.E., et al. Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance. Mol. Microbiol. 2009, 71:240-252.
23. Marcil A., et al. Analysis of PRA1 and its relationship to Candida albicans-macrophage interactions. Infect. Immun. 2008, 76:4345-4358.
24. d'Enfert C. Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr. Opin. Microbiol. 2009, 12:358-364.
25. Vinh D.C., et al. Invasive fungal disease in autosomal-dominant hyper-IgE syndrome. J. Allergy Clin. Immunol. 2010, 125:1389-1390.
26. Ferwerda B., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 2009, 361:1760-1767.
27. van der Velden W.J., et al. Host-microbe interactions in stem cell transplantation: recognizing Candida in infection and inflammation. Virulence 2010, 1:180-184.
28. Glocker E.O., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 2009, 361:1727-1735.
29. Mezger M., et al. Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and influence CXCL10 expression in monocyte-derived dendritic cells. Blood 2008, 111:534-536.
30. Sainz J., et al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int. J. Immunopathol. Pharmacol. 2010, 23:423-436.
31. Mezger M., et al. Genetic susceptibility to infections with Aspergillus fumigatus. Crit. Rev. Microbiol. 2010, 36:168-177.
32. Carvalho A., et al. Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation. Bone Marrow Transplant. 2010, 45:1645-1652.
33. Puel A., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
34. Napolitani G., et al. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 2005, 6:769-776.
35. Rizzetto L., et al. Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism. J. Immunol. 2010, 184:4258-4268.
36. Huang Q., et al. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
37. Loeffler J., et al. Interaction analyses of human monocytes co-cultured with different forms of Aspergillus fumigatus. J. Med. Microbiol. 2009, 58:49-58.
38. Rubin-Bejerano I., et al. Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:11007-11012.
39. Lorenz M.C., et al. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 2004, 3:1076-1087.
40. Fradin C., et al. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 2005, 56:397-415.
41. Rizzetto L., Cavalieri D. A systems biology approach to the mutual interaction between yeast and the immune system. Immunobiology 2010, 215:762-769.
42. Morton C.O., et al. The temporal dynamics of differential gene expression in Aspergillus fumigatus interacting with human immature dendritic cells in vitro. PLoS ONE 2011, 6:e16016.
43. Huang H., et al. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect. Immun. 2009, 77:1774-1781.
44. Mortazavi A., et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5:621-628.
45. Bonifazi P., et al. Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. Mucosal Immunol. 2010, 3:193-205.
46. Spinnler K., et al. Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus. Med. Mycol. 2010, 48:589-597.
47. Martinez-Solano L., et al. Proteomics of RAW 264.7 macrophages upon interaction with heat-inactivated Candida albicans cells unravel an anti-inflammatory response. Proteomics 2009, 9:2995-3010.
48. Martinez-Solano L., et al. Differential protein expression of murine macrophages upon interaction with Candida albicans. Proteomics 2006, 6(Suppl. 1):S133-S144.
49. Fernandez-Arenas E., et al. Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction. Mol. Cell. Proteomics 2007, 6:460-478.
50. Ramirez M.A., Lorenz M.C. Mutations in alternative carbon utilization pathways in Candida albicans attenuate virulence and confer pleiotropic phenotypes. Eukaryot. Cell 2007, 6:280-290.
51. Dagenais T.R., Keller N.P. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin. Microbiol. Rev. 2009, 22:447-465.
52. Almeida R.S., et al. Candida albicans iron acquisition within the host. FEMS Yeast Res. 2009, 9:1000-1012.
53. Linde J., et al. Regulatory network modelling of iron acquisition by a fungal pathogen in contact with epithelial cells. BMC Syst. Biol. 2010, 4:148.
54. Lopez A., et al. Chemical-genetic approaches for exploring the mode of action of natural products. Prog. Drug Res. 2008, 66: 237:239-271.
55. Smith A.M., et al. Quantitative phenotyping via deep barcode sequencing. Genome Res. 2009, 19:1836-1842.
56. Mech F., et al. Automated image analysis of the host-pathogen interaction between phagocytes and Aspergillus fumigatus. PLoS ONE 2011, 6:e19591.
57. Dujon B. Yeast evolutionary genomics. Nat. Rev. Genet. 2010, 11:512-524.
58. Borneman A.R., et al. Whole-genome comparison reveals novel genetic elements that characterize the genome of industrial strains of Saccharomyces cerevisiae. PLoS Genet. 2011, 7:e1001287.
59. Khaldi N., et al. Evidence for horizontal transfer of a secondary metabolite gene cluster between fungi. Genome Biol. 2008, 9:R18.
60. Tavanti A., et al. Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection. Microbes Infect. 2006, 8:791-800.
61. Bruno V.M., et al. Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq. Genome Res. 2010, 20:1451-1458.
62. Wang Y.C., et al. Global screening of potential Candida albicans biofilm-related transcription factors via network comparison. BMC Bioinform. 2010, 11:53.
63. Becker J.M., et al. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:22044-22049.
64. de Llanos R., et al. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits. Int. J. Food Microbiol. 2011, 144:393-399.
65. Rao R.P., et al. Aberrant synthesis of indole-3-acetic acid in Saccharomyces cerevisiae triggers morphogenic transition, a virulence trait of pathogenic fungi. Genetics 2010, 185:211-220.
66. Diezmann S., Dietrich F.S. Saccharomyces cerevisiae: population divergence and resistance to oxidative stress in clinical, domesticated and wild isolates. PLoS ONE 2009, 4:e5317.
67. Liti G., et al. Population genomics of domestic and wild yeasts. Nature 2009, 458:337-341.
68. Klingberg T.D., et al. Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits. FEMS Yeast Res. 2008, 8:631-640.
69. Kumar A., et al. Converging evidence of mitochondrial dysfunction in a yeast model of homocysteine metabolism imbalance. J. Biol. Chem. 2011, 286:21779-21795.
70. Diezmann S., Dietrich F.S. Oxidative stress survival in a clinical Saccharomyces cerevisiae isolate is influenced by a major QTN. Genetics 2011, 188:709-722.